Clinical trialNo phase (not a drug trial)Active not recruiting
High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma
Advancing The Local Staging Of Pancreatic Ductal Adenocarcinoma Through High-Resolution Ultrasound: A Pilot Study
- Outcome
- Ongoing
- Phase
- No phase (not a drug trial)
- Status
- Active not recruiting
- Study type
- Interventional
- Start
- 1 February 2019
- Expected end
- December 2026
- Enrollment
- 30 participants
- Sites
- 1
- Primary outcomes
- High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDAC
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 10 October 2024
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is being done to see if using high resolution ultrasound before and during surgery will help the doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has spread to other areas of the body.